Skip to main content
. 2021 Jan 7;27(2):214–218. doi: 10.5152/dir.2021.19545

Table 1.

Clinical, morphological and safety data of the analyzed samples

Unselected pool of patients
Total patients, n 361
Age (years), mean (min–max) 69.7 (31–93)
Sex, n 233 M, 128 F
Diagnosis Neoplastic 260/361 (72%)
Non-neoplastic 78/361 (21.6%)
Nondiagnostic 23/361 (6.4%)

Tumoral lesions
Age (years), mean (min–max) 70.8 (31–93)
Sex, n 176 M, 84 F
Dimensions of the nodule (mm), min–max 8–130
NSCLC 192/260 (73.8%)
Mix of SCLC 68/260 (26.2%)
Safety

Complications No or early minor complications 184/192 (96%)
Major complications 8/192 (4%)

Data are presented as ratio of patients (percentage), unless otherwise noted.

NSCLC, non-small cell lung carcinoma; SCLC, small cell lung carcinoma.